Jieming Li
Impact in
-
- Gallbladder and Bile Duct Disorders
- Biliary and Gastrointestinal Fistulas
-
- Pediatric Hepatobiliary Diseases and Treatments
Papers in ⓘ
-
- Ovarian function and disorders 3
-
- Cell Adhesion Molecules Research 2
- Co-authors
- Zhitao Dong (4 shared papers)Guozhong Wu (4 shared papers)Weijie Zhang (2 shared papers)Guifang Xu (1 shared paper)Xiao‐Dong Mo (1 shared paper)Xin-Zhou Li (1 shared paper)Hongbo Cheng (1 shared paper)Hai Qian (4 shared papers)
- Journals
- Medicine (2 papers)Journal of Surgical Research (2 papers)Bioorganic & Medicinal Chemistry (2 papers)Frontiers in Immunology (1 paper)Tumor Biology (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Jieming Li
19 papers receiving 398 citations
Peers
Comparison fields: 5 of 68
- Pulmonary and Respiratory Medicine 217
- Surgery 211
- Oncology 109
- Reproductive Medicine 28
- Emergency Medicine 24
Countries citing papers authored by Jieming Li
This map shows the geographic impact of Jieming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieming Li more than expected).
Fields of papers citing papers by Jieming Li
This network shows the impact of papers produced by Jieming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieming Li. The network helps show where Jieming Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jieming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 66 | |
| 2 | 2009 | 58 | |
| 3 | 2008 | 46 | |
| 4 | 2015 | 39 | |
| 5 | 1997 | 35 | |
| 6 | 2017 | 27 | |
| 7 | 2020 | 21 | |
| 8 | 2016 | 18 | |
| 9 | 2015 | 18 | |
| 10 | 2018 | 15 | |
| 11 | 2017 | 13 | |
| 12 | 2023 | 13 | |
| 13 | Integrin-associated CD151 is a suppressor of prostate cancer progression. | 2020 | 10 |
| 14 | 2019 | 9 | |
| 15 | [Survey of health status and healthcare service demand of perimenopausal women in Guangdong]. | 2004 | 6 |
| 16 | 2019 | 6 | |
| 17 | 2025 | 4 | |
| 18 | 2000 | 4 | |
| 19 | 2023 | 1 |
About Jieming Li
Jieming Li is a scholar working on Reproductive Medicine, Immunology and Allergy, Sensory Systems, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 19 papers that have together received 409 indexed citations. Recurring topics across this work include Biliary and Gastrointestinal Fistulas (4 papers), Gallbladder and Bile Duct Disorders (4 papers), Reproductive Biology and Fertility (3 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), Ovarian function and disorders (3 papers), Cell Adhesion Molecules Research (2 papers), Lipid metabolism and disorders (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (217 citations), Surgery (211 citations), Oncology (109 citations), Reproductive Medicine (28 citations) and Emergency Medicine (24 citations). Jieming Li has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Zhitao Dong, Guozhong Wu, Weijie Zhang, Guifang Xu, Xiao‐Dong Mo, Xin-Zhou Li, Hongbo Cheng, Hai Qian, Chunxia Liu and Chen Liao. Their work appears in journals such as Medicine, Journal of Surgical Research, Bioorganic & Medicinal Chemistry, Frontiers in Immunology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.